Insider · CIK 0001682069

Burke William P. Mr.

Reports to the SEC for 4 companies · ALACHUA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001682069

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,392 sh	—	—	4,392
2026-06-19	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	—	—	0
2026-06-19	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	—	—	14,250
2025-11-11	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−3,591 sh	—	—	0
2025-11-11	AXGNAxogen, Inc.S Sale	Director	SSale	−3,591 sh	$24.02	−$86.2K	100
2025-11-11	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,591 sh	$8.14	+$29.2K	3,691
2025-11-10	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19.2K sh	$8.14	+$157K	19,327
2025-11-10	AXGNAxogen, Inc.S Sale	Director	SSale	−19.2K sh	$24.01	−$462K	100
2025-11-10	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−19.2K sh	—	—	3,591
2025-11-06	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−5,347 sh	—	—	22,818
2025-11-06	AXGNAxogen, Inc.S Sale	Director	SSale	−5,347 sh	$24.01	−$128K	100
2025-11-06	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,347 sh	$8.14	+$43.5K	5,447
2025-11-05	AXGNAxogen, Inc.S Sale	Director	SSale	−11.4K sh	$24.05	−$275K	100
2025-11-05	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−11.4K sh	—	—	28,165
2025-11-05	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.4K sh	$8.14	+$93K	11,531
2025-10-30	AXGNAxogen, Inc.S Sale	Director	SSale	−18.2K sh	$23.00	−$420K	100
2025-10-30	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.2K sh	$7.04	+$128K	18,348
2025-10-30	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−18.2K sh	—	—	0
2025-10-29	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−19.8K sh	—	—	39,596
2025-10-29	AXGNAxogen, Inc.S Sale	Director	SSale	−20.4K sh	$19.15	−$391K	100
2025-10-29	AXGNAxogen, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20.4K sh	—	—	0
2025-10-29	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20.4K sh	$6.30	+$129K	20,536
2025-10-29	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19.8K sh	$8.14	+$161K	19,899
2025-10-29	AXGNAxogen, Inc.S Sale	Director	SSale	−19.8K sh	$22.00	−$436K	100
2025-10-22	AXGNAxogen, Inc.S Sale	Director	SSale	−1,457 sh	$18.02	−$26.3K	100
2025-10-06	AXGNAxogen, Inc.S Sale	Director	SSale	−736 sh	$18.00	−$13.2K	1,557
2025-10-03	AXGNAxogen, Inc.S Sale	Director	SSale	−7,600 sh	$18.21	−$138K	0
2025-10-03	AXGNAxogen, Inc.S Sale	Director	SSale	−14.6K sh	$18.21	−$265K	2,293
2025-10-02	AXGNAxogen, Inc.S Sale	Director	SSale	−2,400 sh	$18.01	−$43.2K	7,600
2025-10-02	AXGNAxogen, Inc.S Sale	Director	SSale	−7,620 sh	$18.01	−$137K	16,864
2025-06-19	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+14.2K sh	—	—	14,150
2025-06-09	AXGNAxogen, Inc.S Sale	Director	SSale	−4,073 sh	$10.61	−$43.2K	24,484
2024-09-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	0
2024-09-01	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	—	—	28,557
2024-06-06	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)A Award	Director	AAward	+18.2K sh	—	—	18,248
2024-06-06	AXGNAxogen, Inc.A Award	Director	AAward	+10.7K sh	—	—	16,653
2023-12-13	Miromatrix Medical Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−67.4K sh	—	—	0
2023-12-12	Miromatrix Medical Inc.U Disposition from Tender	Director	UDisposition from Tender	−66.9K sh	—	—	67,413
2023-09-01	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)A Award	Director	AAward	+20.4K sh	—	—	20,436
2023-09-01	AXGNAxogen, Inc. · Common StockA Award	Director	AAward	+11.9K sh	—	—	11,904
2023-08-24	AXGNAxogen, Inc.A Award	Director	AAward	+6,000 sh	$6.31	+$37.9K	6,000
2023-08-23	AXGNAxogen, Inc.P Purchase	Director	PPurchase	+10K sh	$6.56	+$65.6K	10,000
2023-06-01	Miromatrix Medical Inc.A Award	Director	AAward	+54.2K sh	—	—	134,356
2023-03-10	Miromatrix Medical Inc.P Purchase	Director	PPurchase	+31.3K sh	$1.60	+$50K	80,155
2023-03-01	ViewRay, Inc.Performance UnitsA Award	Chief Financial Officer	AAward	+104K sh	—	—	103,686
2023-03-01	ViewRay, Inc.A Award	Chief Financial Officer	AAward	+104K sh	—	—	356,318
2023-01-16	ViewRay, Inc.A Award	Chief Financial Officer	AAward	+253K sh	—	—	252,632
2022-08-10	Miromatrix Medical Inc.A Award	Director	AAward	+12.8K sh	—	—	48,905
2022-07-19	AXGNAxogen, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+59.4K sh	$8.14	+$483K	0
2022-01-03	Miromatrix Medical Inc.A Award	Director	AAward	+31.7K sh	—	—	36,117

Recent filings

Accepted (ET)
Jun 264
Burke William P. Mr.0001682069-26-000002
SEC(opens sec.gov)
Jun 234
Burke William P. Mr.0000805928-26-000076
SEC(opens sec.gov)
Nov 134
Burke William P. Mr.0000805928-25-000136
SEC(opens sec.gov)
Nov 74
Burke William P. Mr.0000805928-25-000134
SEC(opens sec.gov)
Oct 314
Burke William P. Mr.0000805928-25-000132
SEC(opens sec.gov)

Companies

Address

C/O AXOGEN, INC. 13631 PROGRESS BLVD. SUITE 400

ALACHUA, FL, 32615